Finnhub•2026-04-15
SS Innovations International : Statement of changes in beneficial ownership of securities - Form 4SSII — SS Innovations International Inc
NASDAQ · Health Care · Health Care
$4.60-20.96%Market cap944.57M
- Latest Close
- $4.6
- 30-Day Move
- -21.0%
- Market Cap
- $945M
- Shares Outstanding
- 194,360,000
- P/B Ratio
- 62.18
- ROE
- -105.9%
NASDAQ:SSIIHealth Care / Health CareDelayed public snapshot
SS Innovations International Inc
A read-only Alphactor snapshot forSS Innovations International Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$4.6
30-Day Move
-21.0%
Market Cap
$945M
Shares Outstanding
194,360,000
P/B Ratio
62.18
ROE
-105.9%
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$4.60
-21.0%last 90 delayed daily bars
Market cap$945M
90D High
$6.30
90D Low
$3.11
Avg Volume
84,210
What stands out
Gross margin is running at 32.7%, which gives a quick read on operating quality before you open the full model.
Net margin is -173.8%, useful for comparing SSII against peers in Health Care.
SSII is down 21.0% over the last 30 trading days shown on this page.
Latest operating income is $-734,997, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Composite Fair Value
$1.04
Rule of 40
53.5%
Fundamentals snapshot
Latest Close
$4.6
30-Day Move
-21.0%
Market Cap
$945M
Shares Outstanding
194,360,000
P/B Ratio
62.18
ROE
-105.9%
ROA
-66.3%
Gross Margin
32.7%
Operating Margin
-171.0%
Net Margin
-173.8%
Debt / Equity
0.33
Current Ratio
2.53
Latest Revenue
$15M
Financial statement snapshot
Revenue
$15M
Gross Profit
$6M
Operating Income
$-734,997
Net Income
$-2M
Gross Margin
3272.0%
Net Margin
-17377.0%
Current Ratio
2.53
Debt / Equity
0.33
Valuation snapshot
Fair Value
$1.04
Upside / Downside
-77.4%
Signal
Overvalued
Implied Growth
--
EV/Rev
$1.04
Growth Assumption
50.0%
Discount Rate
9.6%
Terminal Growth
2.0%
Base FCF
--
Valuation spread
Current Price
$4.60
Composite Fair Value
$1.04
EV/Rev
$1.04
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Negative FCF — company is cash-flow negative. Reverse DCF requires positive cash flows.
Quality snapshot
Altman Z
15.26
Safe
Piotroski
5
Moderate (4-6)
Cash Conversion
1.53x
Rule of 40
53.5%
Strong
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $1M | $-3M | $-3M | $-6M |
| 2023-12-31 | $6M | $-20M | $-21M | $-16M |
| 2024-12-31 | $21M | $-19M | $-19M | $-10M |
| 2025-12-31 | $42M | $-8M | $-12M | $-22M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
After signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$5M
Sell Value
$0
Buys
7
Sells
0
Buy Value
$5M
Sell Value
$0
Buy/Sell Ratio
7.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-14 | Sudhir Srivastava | G | 10,000 | $0.00 |
| 2026-04-06 | Cohen Barry F | J | 19,000 | $5.58 |
| 2026-04-01 | Cohen Barry F | G | 7,000 | $0.00 |
| 2026-03-30 | Sudhir Srivastava | G | 246,000 | $0.00 |
| 2026-03-25 | Sudhir Srivastava | G | 10,000 | $0.00 |
| 2026-03-06 | Adams Timothy P. | Buy | 300,000 | $3.99 |
| 2026-03-06 | Sudhir Srivastava | Buy | 498,753 | $4.01 |
| 2026-03-06 | MOLL FREDERIC H | Buy | 501,253 | $3.99 |
Institutional holders snapshot
Geode Capital Management
Filed 2025-11-12
$195,318
+44.6%
Goldman Sachs
Filed 2026-02-10
$67,899
--
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.